BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9512107)

  • 61. Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications.
    Cozzani E; Muracchioli A; Murdaca G; Beccalli M; Caprioli S; Zentilin P; Ameri P; Grosso M; Russo R; Carmisciano L; Parodi A
    Front Immunol; 2021; 12():588753. PubMed ID: 34149680
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Capillary microscopy of the nail fold in Raynaud's phenomenon. Use in the early diagnosis of scleroderma].
    Rivera Redondo J; López Bote JP; Alvaro-Gracia Alvaro JM; Sabando Suárez P; Ossorio Castellanos C
    Rev Clin Esp; 1985 Jun; 177(1):7-10. PubMed ID: 4035042
    [No Abstract]   [Full Text] [Related]  

  • 63. [Variability of the clinical picture and the classification of progressive systemic scleroderma].
    Giordano M; Ara M; Capelli L; Tirri G; Vatti M
    Z Rheumatol; 1976; 35(7-8):286-300. PubMed ID: 961080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Current treatment options in systemic Sclerosis (Scleroderma).
    Stummvoll GH
    Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon.
    Kallenberg CG; Wouda AA; The TH
    Am J Med; 1980 Nov; 69(5):675-80. PubMed ID: 6969028
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Systemic sclerosis in the elderly.
    Czirják L; Nagy Z; Szegedi G
    Clin Rheumatol; 1992 Dec; 11(4):483-5. PubMed ID: 1486736
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical aspects of localized and systemic sclerosis.
    Clements P
    Curr Opin Rheumatol; 1992 Dec; 4(6):843-50. PubMed ID: 1457279
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Systemic scleroderma in children].
    Plantin P; Gavanou J; Le Fur JM; Guillet G
    Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study.
    Trostle DC; Bedetti CD; Steen VD; Al-Sabbagh MR; Zee B; Medsger TA
    Arthritis Rheum; 1988 Mar; 31(3):393-400. PubMed ID: 3358801
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre.
    Lepri G; Guiducci S; Bellando-Randone S; Giani I; Bruni C; Blagojevic J; Carnesecchi G; Radicati A; Pucciani F; Marco MC
    Ann Rheum Dis; 2015 Jan; 74(1):124-8. PubMed ID: 24130266
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Initial visceral involvement with diffuse systemic scleroderma].
    Gruschwitz MS; Steffan C; Albrecht HP; Hornstein OP
    Hautarzt; 1994 Nov; 45(11):787-91. PubMed ID: 7822206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Juvenile systemic sclerosis: experience from a tertiary care center from India.
    Bagri NK; Raj D; Kaur J; Punia H; Saini I; Lodha R; Kabra SK
    Rheumatol Int; 2017 Oct; 37(10):1687-1691. PubMed ID: 28831595
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnosis and Management of Systemic Sclerosis: A Practical Approach.
    Lee JJ; Pope JE
    Drugs; 2016 Feb; 76(2):203-13. PubMed ID: 26659258
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Management of Systemic Sclerosis-Related Skin Disease: A Review of Existing and Experimental Therapeutic Approaches.
    Volkmann ER; Furst DE
    Rheum Dis Clin North Am; 2015 Aug; 41(3):399-417. PubMed ID: 26210126
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Raynaud, digital ulcers and calcinosis in scleroderma.
    Nitsche A
    Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Progressive systemic sclerosis in Auckland: a ten year review with emphasis on prognostic features.
    Eason RJ; Tan PL; Gow PJ
    Aust N Z J Med; 1981 Dec; 11(6):657-62. PubMed ID: 6949543
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Scleroderma in children.
    Cassidy JT; Sullivan DB; Dabich L; Petty RE
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):351-4. PubMed ID: 263912
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Systemic sclerosis].
    Kleinert S; Tony HP; Kneitz C
    Internist (Berl); 2006 Oct; 47(10):1051-61; quiz 1062. PubMed ID: 16972070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.